Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study of Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease

NCT01036802 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT01036802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01036802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study of Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2009
Completion date
September 30, 2012
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary hypertension